Clarentis Technologies Overview

  • Founded
  • 2010

  • Status
  • Private

  • Employees
  • 3

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

Clarentis Technologies General Information


Manufacturer of non-toxic disinfectant and anti-microbial devices designed to generate high-quality, pure, and effective green sanitizing disinfection. The company's devices help to kill common bacteria across a broad spectrum of applications and also eradicate antibiotic-resistant strains of the virulent pathogens found around the globe, enabling industrial businesses to reduce the number of chemicals that they use in purification.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Primary Office
  • 4440 PGA Boulevard
  • Suite 600
  • Palm Beach Gardens, FL 33410
  • United States
+1 (561) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clarentis Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Sep-2014 $10M 0000 Completed Generating Revenue
To view Clarentis Technologies’s complete valuation and funding history, request access »

Clarentis Technologies Executive Team (2)

Name Title Board Seat Contact Info
Duke Van Kalken Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Clarentis Technologies Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial